Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2004 May;59(5):372–375. doi: 10.1136/thx.2003.010199

Failure of sputum eosinophilia after eotaxin inhalation in asthma

D Bumbacea 1, J Scheerens 1, B Mann 1, R Stirling 1, K Chung 1
PMCID: PMC1746988  PMID: 15115860

Abstract

Background: Eotaxin is a chemokine specific for eosinophils and may play an important role in eosinophil recruitment in asthma. The effects of eotaxin inhalation on sputum and blood eosinophils, exhaled nitric oxide (NO), and bronchial responsiveness were determined.

Methods: Eotaxin was administered by nebulisation to asthma patients in three studies: (1) an open dose finding study with eotaxin (5, 10 and 20 µg) to two asthmatic subjects; (2) a randomised placebo controlled study with 20 µg eotaxin to five asthmatic subjects and five normal volunteers; and (3) a randomised placebo controlled study with 40 µg eotaxin to nine asthmatics. Forced expiratory volume in 1 second (FEV1), exhaled NO, and blood eosinophils were measured before and hourly for 5 hours after nebulisation and at 24 and 72 hours. Methacholine bronchial challenge and sputum induction were performed before and at 5, 24, and 72 hours after nebulisation.

Results: In the two placebo controlled studies there was no change in sputum eosinophil count and sputum eosinophilic cationic protein concentration after eotaxin inhalation compared with placebo. FEV1, exhaled NO, and methacholine PC20 did not change. However, high dose eotaxin (40 µg) induced an increase in sputum neutrophil count compared with placebo (p<0.05).

Conclusions: Inhaled eotaxin up to 40 µg induced no changes in sputum eosinophil count but at 40 µg it increased the sputum neutrophil count. The significance of this finding is unknown.

Full Text

The Full Text of this article is available as a PDF (228.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonecchi R., Polentarutti N., Luini W., Borsatti A., Bernasconi S., Locati M., Power C., Proudfoot A., Wells T. N., Mackay C. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. J Immunol. 1999 Jan 1;162(1):474–479. [PubMed] [Google Scholar]
  2. Collins P. D., Marleau S., Griffiths-Johnson D. A., Jose P. J., Williams T. J. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995 Oct 1;182(4):1169–1174. doi: 10.1084/jem.182.4.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Conroy D. M., Williams T. J. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res. 2001 Mar 29;2(3):150–156. doi: 10.1186/rr52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Daugherty B. L., Siciliano S. J., DeMartino J. A., Malkowitz L., Sirotina A., Springer M. S. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med. 1996 May 1;183(5):2349–2354. doi: 10.1084/jem.183.5.2349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fukuyama S., Inoue H., Aizawa H., Oike M., Kitaura M., Yoshie O., Hara N. Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo. Am J Respir Crit Care Med. 2000 Jun;161(6):1844–1849. doi: 10.1164/ajrccm.161.6.9905039. [DOI] [PubMed] [Google Scholar]
  6. Griffiths-Johnson D. A., Collins P. D., Rossi A. G., Jose P. J., Williams T. J. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun. 1993 Dec 30;197(3):1167–1172. doi: 10.1006/bbrc.1993.2599. [DOI] [PubMed] [Google Scholar]
  7. Hanazawa T., Antuni J. D., Kharitonov S. A., Barnes P. J. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J Allergy Clin Immunol. 2000 Jan;105(1 Pt 1):58–64. doi: 10.1016/s0091-6749(00)90178-7. [DOI] [PubMed] [Google Scholar]
  8. Hisada T., Hellewell P. G., Teixeira M. M., Malm M. G., Salmon M., Huang T. J., Chung K. F. alpha4 integrin-dependent eotaxin induction of bronchial hyperresponsiveness and eosinophil migration in interleukin-5 transgenic mice. Am J Respir Cell Mol Biol. 1999 May;20(5):992–1000. doi: 10.1165/ajrcmb.20.5.3473. [DOI] [PubMed] [Google Scholar]
  9. Jose P. J., Griffiths-Johnson D. A., Collins P. D., Walsh D. T., Moqbel R., Totty N. F., Truong O., Hsuan J. J., Williams T. J. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med. 1994 Mar 1;179(3):881–887. doi: 10.1084/jem.179.3.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Keatings V. M., Evans D. J., O'Connor B. J., Barnes P. J. Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax. 1997 Apr;52(4):372–374. doi: 10.1136/thx.52.4.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lamkhioued B., Renzi P. M., Abi-Younes S., Garcia-Zepada E. A., Allakhverdi Z., Ghaffar O., Rothenberg M. D., Luster A. D., Hamid Q. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol. 1997 Nov 1;159(9):4593–4601. [PubMed] [Google Scholar]
  12. Mattoli S., Stacey M. A., Sun G., Bellini A., Marini M. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun. 1997 Jul 18;236(2):299–301. doi: 10.1006/bbrc.1997.6958. [DOI] [PubMed] [Google Scholar]
  13. Menzies-Gow Andrew, Ying Sun, Sabroe Ian, Stubbs Victoria L., Soler Dulce, Williams Timothy J., Kay A. Barry. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol. 2002 Sep 1;169(5):2712–2718. doi: 10.4049/jimmunol.169.5.2712. [DOI] [PubMed] [Google Scholar]
  14. Ponath P. D., Qin S., Post T. W., Wang J., Wu L., Gerard N. P., Newman W., Gerard C., Mackay C. R. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med. 1996 Jun 1;183(6):2437–2448. doi: 10.1084/jem.183.6.2437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stirling R. G., Kharitonov S. A., Campbell D., Robinson D. S., Durham S. R., Chung K. F., Barnes P. J. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group. Thorax. 1998 Dec;53(12):1030–1034. doi: 10.1136/thx.53.12.1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stirling R. G., van Rensen E. L., Barnes P. J., Chung K. F. Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1403–1409. doi: 10.1164/ajrccm.164.8.2010002. [DOI] [PubMed] [Google Scholar]
  17. Woodhead M. Community-acquired pneumonia guidelines: much guidance, but not much evidence. Eur Respir J. 2002 Jul;20(1):1–3. doi: 10.1183/09031936.02.01042002. [DOI] [PubMed] [Google Scholar]
  18. Ying S., Meng Q., Zeibecoglou K., Robinson D. S., Macfarlane A., Humbert M., Kay A. B. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol. 1999 Dec 1;163(11):6321–6329. [PubMed] [Google Scholar]
  19. Zeibecoglou K., Ying S., Meng Q., Kay A. B., Robinson D. S., Papageorgiou N. Expression of eotaxin in induced sputum of atopic and nonatopic asthmatics. Allergy. 2000 Nov;55(11):1042–1048. doi: 10.1034/j.1398-9995.2000.00764.x. [DOI] [PubMed] [Google Scholar]
  20. van de Rijn M., Mehlhop P. D., Judkins A., Rothenberg M. E., Luster A. D., Oettgen H. C. A murine model of allergic rhinitis: studies on the role of IgE in pathogenesis and analysis of the eosinophil influx elicited by allergen and eotaxin. J Allergy Clin Immunol. 1998 Jul;102(1):65–74. doi: 10.1016/s0091-6749(98)70056-9. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES